Lonza (Basel, Switzerland) formally promoted its DHAid line of algae-derived, vegetarian DHA omega-3 fatty acid.
Lonza (Basel, Switzerland) formally promoted its DHAid line of algae-derived, vegetarian DHA omega-3 fatty acid. The DHAid line includes two oil-based ingredients and one powdered ingredient. DHAid FNO-350 is a nutritional oil containing 350 mg DHA/g and is suited for food applications. The other oil ingredient, DHAid CL-400, is a clear oil offering 400 mg DHA/g and targets dietary supplements. Lonza says that both oil products are standardized with oleic sunflower oil to allow for a more precise calculation of the final DHA omgea-3 concentration in finished products. The line’s powder ingredient is called DHAid Dry and is suited for applications in dry blends, such as nutrition beverages. New suppliers are appearing on the algal DHA scene, and a representative from Lonza told us that it’s significant that DHAid “is now another option. We’re just trying to get the message out that there is another option on the market.”
GC Rieber VivoMega uses AI platform from Intelecy to boost efficiency, quality, and sustainability
August 26th 2024According to the company’s announcement, the AI platform is able to identify real-time deviations or anomalies in GC Rieber VivoMega’s processing facilities and report them via a cloud-based, comprehensive, centralized system.
SourceOne Global Partners to distribute Qualitas Health’s microalgae omega-3 ingredient globally
August 15th 2024SourceOne Global Partners has announced a partnership with Qualitas Health Inc., (dba iwi life) to introduce the company’s trademarked AlmegaPL microalgae omega-3 ingredient to the global marketplace.
Recent animal study finds that Lysoveta may help reduce neonatal brain injury
July 17th 2024A recent animal study found that lysophosphatidylcholine (LPC)-bound omega-3 long-chain polyunsaturated fatty acids (LCPUFAs), marketed as Lysoveta by Aker BioMarine, protected against neonatal hypoxic-ischemic (HI) brain injury in mice.